Date: December 8-11, 2007

Loacation: Atlanta, Georgia

Thrombopoietin Receptor Agonists & Immune Thrombocytopenic Purpura (ITP): A Report from the 2007 American Society of Hematology (ASH) Meeting

Charles S. Abrams, MD, Associate Professor of Medicine, Director, Thrombophilia Program, University of Pennsylvania Health System, Philadelphia, Pennsylvania

Advances in the Management of Chronic Myeloid Leukemia: A Report from the 2007 American Society of Hematology (ASH) Meeting

Hagop M. Kantarjian, MD, Chairman & Professor, Leukemia Department, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Updates in the Management of Myelodysplastic Syndromes: A Report from the 2007 American Society of Hematology (ASH) Meeting

Mikkael A. Sekeres, MD, MS, Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio

Recommended Articles

Image placeholder title

Ask the Experts About Circulating Tumor DNA in the Management of Cancer

Ask the Experts About Circulating Tumor DNA (ctDNA) in the Management of Cancer

Image placeholder title

Tisotumab Vedotin – Promising in Advanced Cervical Cancer

Novel precision cancer medicine promising for treatment of advanced ovarian cancer.

Image placeholder title

Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer

Checkpoint inhibitor immunotherapy prolongs survival and delays recurrence in advanced cervical cancer.

Supportive Care and Hematologic Malignancies: Updates from the 2007 American Society of Hematology (ASH) Meeting

C. Dean Buckner, MD, Founding Member, Fred Hutchinson Cancer Research Center